Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
399
archived clinical trials in
Infertility

Ovarian Follicle Function in Patients With Primary Ovarian Failure
Ovarian Follicle Function in Patients With Primary Ovarian Insufficiency
Status: Enrolling
Updated:  10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Ovarian Follicle Function in Patients With Primary Ovarian Failure
Ovarian Follicle Function in Patients With Primary Ovarian Insufficiency
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Pre-Exposure Prophylaxis and Timed Intercourse for HIV-Discordant Couples
Pre-Exposure Prophylaxis and Timed Intercourse for HIV-Discordant Couples
Status: Enrolling
Updated:  10/5/2017
Missouri Center for Reproductive Medicine & Fertility
mi
from
Columbia, MO
Pre-Exposure Prophylaxis and Timed Intercourse for HIV-Discordant Couples
Pre-Exposure Prophylaxis and Timed Intercourse for HIV-Discordant Couples
Status: Enrolling
Updated: 10/5/2017
Missouri Center for Reproductive Medicine & Fertility
mi
from
Columbia, MO
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Physicians Research Group
mi
from
Tempe, AZ
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Physicians Research Group
mi
from
Tempe, AZ
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
HRC Fertility
mi
from
Encino, CA
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
HRC Fertility
mi
from
Encino, CA
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Reproductive Associates of Delaware
mi
from
Newark, DE
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Reproductive Associates of Delaware
mi
from
Newark, DE
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
FL Fertility Institution
mi
from
Tampa, FL
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
FL Fertility Institution
mi
from
Tampa, FL
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Georgia Reproductive Specialists
mi
from
Atlanta, GA
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Georgia Reproductive Specialists
mi
from
Atlanta, GA
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Fertility Centers of Illinois
mi
from
Chicago, IL
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Fertility Centers of Illinois
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Shady Grove Fertility RSC
mi
from
Rockville, MD
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Shady Grove Fertility RSC
mi
from
Rockville, MD
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
The Nevada Center for Reproductive Medicine
mi
from
Reno, NV
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
The Nevada Center for Reproductive Medicine
mi
from
Reno, NV
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Cooper Institute of Reproductive Hormonal Disorders, P.C.
mi
from
Marlton, NJ
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Cooper Institute of Reproductive Hormonal Disorders, P.C.
mi
from
Marlton, NJ
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Institute for Reproductive Health
mi
from
Cincinnati, OH
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Institute for Reproductive Health
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Abington Reproductive Medicine, PC
mi
from
Abington, PA
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Abington Reproductive Medicine, PC
mi
from
Abington, PA
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Main Line Fertility Center
mi
from
Bryn Mawr, PA
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Main Line Fertility Center
mi
from
Bryn Mawr, PA
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Shady Grove Fertility RSC, Chesterbrook, PA
mi
from
Chesterbrook, PA
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Shady Grove Fertility RSC, Chesterbrook, PA
mi
from
Chesterbrook, PA
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Univ Of Penn
mi
from
Philadelphia, PA
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Univ Of Penn
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Fertility Associates of Memphis
mi
from
Memphis, TN
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Fertility Associates of Memphis
mi
from
Memphis, TN
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Texas Fertility Center
mi
from
Austin, TX
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Texas Fertility Center
mi
from
Austin, TX
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Center for Assisted Reproduction
mi
from
Bedford, TX
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Center for Assisted Reproduction
mi
from
Bedford, TX
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Fertility Specialists of Houston
mi
from
Houston, TX
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Fertility Specialists of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Houston Fertility Institute
mi
from
Houston, TX
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Houston Fertility Institute
mi
from
Houston, TX
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Center of Reproducitve Medicine
mi
from
Webster, TX
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Center of Reproducitve Medicine
mi
from
Webster, TX
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
Jones Institute of Reproductive Medicine
mi
from
Norfolk, VA
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
Jones Institute of Reproductive Medicine
mi
from
Norfolk, VA
Click here to add this to my saved trials
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated:  10/31/2017
In Via Fertility Specialists
mi
from
Hoffman Estate, IL
Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF
Phase III Investigator and Assessor Blinded 1:1 Randomized, Parallel-group Multicenter Study to Compare Efficacy and Safety of Two r-hFSH Formulations (AFOLIA vs Gonal-f® RFF) in Normal Ovulatory Women 35 to 42 Years Old Undergoing in Vitro Fertilization
Status: Enrolling
Updated: 10/31/2017
In Via Fertility Specialists
mi
from
Hoffman Estate, IL
Click here to add this to my saved trials
Hysteroscopic Assessment of Fallopian Tubal Patency
Hysteroscopic Assessment of Fallopian Tubal Patency
Status: Enrolling
Updated:  11/6/2017
University of Mississippi Medical Center
mi
from
Jackson, MS
Hysteroscopic Assessment of Fallopian Tubal Patency
Hysteroscopic Assessment of Fallopian Tubal Patency
Status: Enrolling
Updated: 11/6/2017
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
Online Mind/Body Program for Fertility
Fertility & Well-Being: Mind/Body Protocol
Status: Enrolling
Updated:  11/10/2017
University of Vermont
mi
from
Burlington, VT
Online Mind/Body Program for Fertility
Fertility & Well-Being: Mind/Body Protocol
Status: Enrolling
Updated: 11/10/2017
University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
Use of Nitric Oxide Metabolites for Predicting Embryo Quality in In-Vitro Fertilization (IVF)
Use of Nitric Oxide Metabolites for Predicting Embryo Quality in In-Vitro Fertilization
Status: Enrolling
Updated:  12/7/2017
Johns Hopkins Fertility Center
mi
from
Lutherville, MD
Use of Nitric Oxide Metabolites for Predicting Embryo Quality in In-Vitro Fertilization (IVF)
Use of Nitric Oxide Metabolites for Predicting Embryo Quality in In-Vitro Fertilization
Status: Enrolling
Updated: 12/7/2017
Johns Hopkins Fertility Center
mi
from
Lutherville, MD
Click here to add this to my saved trials
Incidence of Non Receptive Endometrium in Obese Women
Incidence of Not Receptive Endometrium During the Window of Implantation as Body Mass Index by Testing ERA.
Status: Enrolling
Updated:  12/11/2017
Stamford University
mi
from
Palo Alto, CA
Incidence of Non Receptive Endometrium in Obese Women
Incidence of Not Receptive Endometrium During the Window of Implantation as Body Mass Index by Testing ERA.
Status: Enrolling
Updated: 12/11/2017
Stamford University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Incidence of Non Receptive Endometrium in Obese Women
Incidence of Not Receptive Endometrium During the Window of Implantation as Body Mass Index by Testing ERA.
Status: Enrolling
Updated:  12/11/2017
Baylor College of Medicine
mi
from
Houston, TX
Incidence of Non Receptive Endometrium in Obese Women
Incidence of Not Receptive Endometrium During the Window of Implantation as Body Mass Index by Testing ERA.
Status: Enrolling
Updated: 12/11/2017
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Incidence of Non Receptive Endometrium in Obese Women
Incidence of Not Receptive Endometrium During the Window of Implantation as Body Mass Index by Testing ERA.
Status: Enrolling
Updated:  12/11/2017
IVI Valencia
mi
from
Valencia,
Incidence of Non Receptive Endometrium in Obese Women
Incidence of Not Receptive Endometrium During the Window of Implantation as Body Mass Index by Testing ERA.
Status: Enrolling
Updated: 12/11/2017
IVI Valencia
mi
from
Valencia,
Click here to add this to my saved trials
The Impact of Distress on the IVF Outcome
The Impact of Distress on the IVF Outcome
Status: Enrolling
Updated:  12/19/2017
Boston IVF
mi
from
Waltham, MA
The Impact of Distress on the IVF Outcome
The Impact of Distress on the IVF Outcome
Status: Enrolling
Updated: 12/19/2017
Boston IVF
mi
from
Waltham, MA
Click here to add this to my saved trials
Comparison of Culture Media for in Vitro Embryo Development
Prospective Observational Study Utilizing Next Generation Continuous Single Culture Media (CSCM2) for Comparative in Vitro Embryo Development and Outcome Data
Status: Enrolling
Updated:  12/22/2017
Ovation Fertility - Austin
mi
from
Austin, TX
Comparison of Culture Media for in Vitro Embryo Development
Prospective Observational Study Utilizing Next Generation Continuous Single Culture Media (CSCM2) for Comparative in Vitro Embryo Development and Outcome Data
Status: Enrolling
Updated: 12/22/2017
Ovation Fertility - Austin
mi
from
Austin, TX
Click here to add this to my saved trials
SO+IUI After Operative Laparoscopy in Patients With Advanced Stage Endometriosis
Determining the Fertility Benefit of Immediate SO+IUI After Operative Laparoscopy in Patients With Advanced Stage Endometriosis
Status: Enrolling
Updated:  1/23/2018
Cleveland Clinic Foundation
mi
from
Cleveland, OH
SO+IUI After Operative Laparoscopy in Patients With Advanced Stage Endometriosis
Determining the Fertility Benefit of Immediate SO+IUI After Operative Laparoscopy in Patients With Advanced Stage Endometriosis
Status: Enrolling
Updated: 1/23/2018
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Tolerability and Satisfaction With Evie
Patient Satisfaction and Tolerability With the Evie® Slow-Release Insemination Device: Pilot Study
Status: Enrolling
Updated:  1/26/2018
Women's Institute at Carolinas Medical Center
mi
from
Charlotte, NC
Tolerability and Satisfaction With Evie
Patient Satisfaction and Tolerability With the Evie® Slow-Release Insemination Device: Pilot Study
Status: Enrolling
Updated: 1/26/2018
Women's Institute at Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated:  2/6/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated: 2/6/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated:  2/6/2018
Stanford Univ Med Ctr
mi
from
Stanford, CA
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated: 2/6/2018
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated:  2/6/2018
University of Colorado
mi
from
Aurora, CO
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated: 2/6/2018
University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated:  2/6/2018
Yale University
mi
from
New Haven, CT
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated: 2/6/2018
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated:  2/6/2018
University of Michigan
mi
from
Ann Arbor, MI
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated: 2/6/2018
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated:  2/6/2018
Wayne State University
mi
from
Detroit, MI
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated: 2/6/2018
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated:  2/6/2018
Hackensack University
mi
from
Hackensack, NJ
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated: 2/6/2018
Hackensack University
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated:  2/6/2018
Carolinas Medical Center
mi
from
Charlotte, NC
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated: 2/6/2018
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated:  2/6/2018
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated: 2/6/2018
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated:  2/6/2018
Pennsylvania State University College of Medicine
mi
from
Hershey, PA
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated: 2/6/2018
Pennsylvania State University College of Medicine
mi
from
Hershey, PA
Click here to add this to my saved trials
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated:  2/6/2018
Univ of Pennsylvania
mi
from
Philadelphia, PA
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated: 2/6/2018
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated:  2/6/2018
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated: 2/6/2018
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated:  2/6/2018
University of Vermont
mi
from
Burlington, VT
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Registry of Pregnancies Conceived Following Exposure to Ovulation Stimulation Medications
Status: Enrolling
Updated: 2/6/2018
University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
Global Study of Women's Health
Global Study of Women's Health
Status: Enrolling
Updated:  4/4/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Global Study of Women's Health
Global Study of Women's Health
Status: Enrolling
Updated: 4/4/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Effect of Acupuncture on Vascular Biomarkers and Psychological Well-Being of Women Undergoing IVF
Effect of Acupuncture on Vascular Biomarkers and Psychological Well-Being of Women Undergoing In Vitro Fertilization (IVF)
Status: Enrolling
Updated:  4/23/2018
Texas Tech Health Science Center
mi
from
Lubbock, TX
Effect of Acupuncture on Vascular Biomarkers and Psychological Well-Being of Women Undergoing IVF
Effect of Acupuncture on Vascular Biomarkers and Psychological Well-Being of Women Undergoing In Vitro Fertilization (IVF)
Status: Enrolling
Updated: 4/23/2018
Texas Tech Health Science Center
mi
from
Lubbock, TX
Click here to add this to my saved trials